Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran vs Warfarin in AF After Mitral Valve Replacement
NCT03183843Phase 4Unknown
- Sponsor
- Research Institute for Complex Problems of Cardiovascular Diseases
- Start
- Jun 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dabigatran etexilate oral solution in Atrial fibrillation (AFib) (2 arms), sponsored by Research Institute for Complex Problems of Cardiovascular Diseases. Primary endpoint: Thrombosis at 1 year. Status: unknown.
02
Drugs
dabigatran etexilate oral solution
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03183843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183843.